SymKardia, Inc.
New Form D on file · 2026-06-18 · the record
What the record says
Trailing twelve months. 810 filings in Other Health Care, totalled by week. The dot is this raise, $500K, on the same scale — one filing against the whole group's total, so it sits low by construction.
Company officers on record
Anthony Caparso is named as Executive Officer and Director on the Form D that SymKardia, Inc. filed with the SEC on 18 June 2026, one of 11 people that filing names.
Bruce KenKnight is named as Executive Officer on the Form D that SymKardia, Inc. filed with the SEC on 18 June 2026, one of 11 people that filing names.
Steven Girouard is named as Executive Officer on the Form D that SymKardia, Inc. filed with the SEC on 18 June 2026, one of 11 people that filing names.
Jonathan Piccini is named as Executive Officer on the Form D that SymKardia, Inc. filed with the SEC on 18 June 2026, one of 11 people that filing names.
Imad Libbus is named as Executive Officer on the Form D that SymKardia, Inc. filed with the SEC on 18 June 2026, one of 11 people that filing names.
Dwight Skinner is named as Executive Officer on the Form D that SymKardia, Inc. filed with the SEC on 18 June 2026, one of 11 people that filing names.
Robert Picarel is named as Director on the Form D that SymKardia, Inc. filed with the SEC on 18 June 2026, one of 11 people that filing names.
Arun Sridhar is named as Director on the Form D that SymKardia, Inc. filed with the SEC on 18 June 2026, one of 11 people that filing names.
Claudio Rumazza is named as Director on the Form D that SymKardia, Inc. filed with the SEC on 18 June 2026, one of 11 people that filing names.
Alain Garcinuno Collet is named as Director on the Form D that SymKardia, Inc. filed with the SEC on 18 June 2026, one of 11 people that filing names.
James Blouzard is named as Director on the Form D that SymKardia, Inc. filed with the SEC on 18 June 2026, one of 11 people that filing names.
11 people named on the filing — 6 holding an executive role and 5 as directors only.
Named as of the 2026-06-18 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
- 11 people named on the filing — 6 holding an executive role and 5 as directors only.
No investor is drawn from a Form D — the form states how many invested and never who.
The full profile
Source Check, INVEST, RECRUIT and Press Requests on SymKardia, Inc.
- Source Check — verify Anthony Caparso's other claims against the registers that hold them.
- INVEST — size up this raise on the figures the filing states.
- RECRUIT — see who is already on the team.
- Press Requests — connect with Anthony Caparso for a story.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist SymKardia, Inc.You get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind SymKardia, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. FoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.